Dr. Joseph Scott Strickland, D.M.D Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2310 Whitesburg Dr S, Suite F, Huntsville, AL 35801 Phone: 256-533-2667 |
Dr. John Douglas Booth, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2410 L And N Drive, Suite A, Huntsville, AL 35801 Phone: 256-533-4770 Fax: 256-489-4770 |
Dr. James Ronald Guy, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 301 Williams Ave Se, Huntsville, AL 35801 Phone: 256-533-4228 |
Dr. John David Reed, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2338 Pansy St Sw, Huntsville, AL 35801 Phone: 256-533-6006 Fax: 256-533-6022 |
Dr. Rene' Alane Talbot, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 4000 Balmoral Dr Sw Ste 202, Huntsville, AL 35801 Phone: 256-881-8181 |
News Archive
Surgeons from the Instituto de Patologia da Coluna in Sao Paulo, Brazil have found that an innovative minimally invasive surgical procedure performed to achieve two-level axial lumbar interbody fusion produced immediate successful results, but within 2 years complications set in, making the procedure far less desirable.
It is something of an eternal question: Can we slow or even reverse the aging process? Even though genetic manipulations can, in fact, alter some cellular dynamics, little is known about the mechanisms of the aging process in living organisms.
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced it will assemble a group of leading scientific experts at the American Chemical Society's ("ACS") 240th National Meeting & Exposition for a three-day thought leadership summit on the advancement of nanotechnology in the pharmaceutical and diagnostic industries.
Nonarteritic anterior ischemic optic neuropathy is one of the leading causes of sudden and irreversible loss of vision in older adults. In a prospective randomized trial of 60 patients with NAION, investigators have shown that the addition of the corticosteroid fluocortolone to standard therapy significantly improves both short- and long-term visual acuity, especially when given soon after the onset of symptoms. Their results are published in Restorative Neurology and Neuroscience.
› Verified 8 days ago